Navigation Links
Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate

CAMBRIDGE, Mass., June 18, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. today announced the results of two new studies comparing a powder form of Renvela (sevelamer carbonate) to Renagel tablets (sevelamer hydrochloride), including one trial in which patients received the powder form three times per day, and one in which it was administered once per day.

Genzyme is developing Renvela in powder form to provide an additional option for patients with chronic kidney disease in managing their phosphate levels. A New Drug Application for Renvela tablets is already on file with the FDA, and previous studies have shown that the tablet formulation provides equivalent phosphate control to Renagel in patients on dialysis and significant phosphorus control in patients with chronic kidney disease who are not on dialysis. Today's results are the first from trials comparing the efficacy of the powder form of Renvela to Renagel tablets.

In the first powder trial, patients treated with the powder form of Renvela three times per day experienced equivalent phosphorus control to patients treated with Renagel tablets three times per day. As a result, this trial successfully met its primary endpoint.

In the second trial, patients dosed with the powder form of Renvela once per day and those treated with Renagel tablets three times per day achieved statistically significant reductions in serum phosphorus, with both groups reaching target levels for phosphorus control outlined in the K/DOQI treatment guidelines. Phosphorus levels in the Renagel arm (4.6 mg/dL) were lower than those in the Renvela arm (5.3 mg/dL), and this trial did not achieve its primary endpoint of demonstrating non-inferiority of Renvela powder dosed once per day to Renagel tablets dosed three times per day.

In both trials, the safety profile of Renvela was consistent with the previous clinical experience of patients on dialysis using Ren
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
5. Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients With Chronic Kidney Disease
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/28/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report  "RNAi - ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... involves the use of double stranded RNA ... is processed into short 21-23 nucleotide RNAs ...
(Date:5/28/2015)... 28, 2015 Henry Schein , ... of health care products and services to office-based ... its customers that the Henry Schein Disaster Relief ... who experience operational, logistical or financial issues as ... South Central region of the U.S. The toll-free ...
(Date:5/28/2015)... CENTENNIAL, Colo. , May 28, 2015 /PRNewswire-USNewswire/ ... largest providers of cartilage, cellular, bone, skin and ... wound care to advance patient healing, today announced ... allograft, has been moved to the high-cost reimbursement ... our allografts reach doctors and their patients," said ...
Breaking Medicine Technology:Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced that ... ), has exercised its option under the terms ... research period for an,additional one-year period through Dec. ... extension, Wyeth,s obligations to Trubion include,collaboration research funding ...
... Community Oncology,Research Network(TM) (ACORN) will be showcasing ... PACE(TM) PRO System; and,proprietary oncology-focused data warehouse ... in Boston, MA., (Logo: http://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOGO ... company announced its Contract Research Organization,(CRO) exceeded ...
Cached Medicine Technology:Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 2Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration 3ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting 2
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... May 29, 2015 OncLive proudly announces ... dozen medical pioneers recognized by a panel of eminent ... of cancer treatment. Honorees will be introduced and celebrated ... Award Ceremony, held 8:30-11:00 p.m. CDT at The Chicago ... honorees are being recognized for groundbreaking accomplishments, in fields ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 Oaksterdam University, the ... June, this time to host its popular and highly demanded ... 14, and 15 from 10:00 am to 5:30 pm each day. ... Cannabis Job Fair will be held on June 14 from ... Fair will be held at the Plaza Hotel & Casino in ...
(Date:5/29/2015)... 29, 2015 Designed with the versatile ... to create an all new, exclusive line of supplementation ... with the latest and greatest, high impact, result driven ... be effective. The 24/7 Series can be used by ... even the casual fitness enthusiasts. There are no stimulant ...
(Date:5/29/2015)... MN (PRWEB) May 29, 2015 As ... Patio and Metro series outdoor saunas have increased in ... landscaping projects, and work at summer cottages. While ... piqued interest in summer projects a few weeks earlier ... suburban communities with smaller lot sizes tend to prefer ...
Breaking Medicine News(10 mins):Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:As Summer Approaches, Finnleo Notes Increased Interest in Patio and Metro Outdoor Saunas 2
... GMPs and adverse event reportingWASHINGTON, March 2 ... Accountability Office (GAO) of a report on the ... Products Association (NPA) released the following statement from ... Association appreciates having the opportunity to be included ...
... Commission wildlife biologists continue to monitor bat hibernacula, the ... or dying from White Nose Syndrome (WNS) has risen ... Carbondale, Lackawanna County; an abandoned mine near Shickshinny, Luzerne ... and Seawra Cave in Mifflin County."We continue to receive ...
... Increases 72% from Prior YearDUBLIN, Calif., March 2 ... company dedicated to the discovery and development of novel ... quarter and year ended December 31, 2008. The Company ... of $2.6 million, or $0.04 per share, compared with ...
... March 2 Align Technology, Inc. (Nasdaq: ... of Invisalign Teen(TM) for non-adult, comprehensive orthodontic treatment. ... and demonstrated effectiveness of the Invisalign(R) system, with ... of permanent teeth, and root-movement control - issues ...
... HOLLYWOOD, Calif., March 2 IPC The Hospitalist Company, Inc. (Nasdaq: ... today announced financial results for the fourth quarter and full year ... , Net revenue ... area net revenue growth of 19% , ...
... and T-shirts are likely to drink more or become binge ... All those T-shirts, hats and other items promoting alcoholic beverages ... fashion statement. , , Teens who own such merchandise are ... new study contends. , The Dartmouth scientists who did the ...
Cached Medicine News:Health News:Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements 2Health News:WNS Identified at Six Sites in Pennsylvania 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 2Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 3Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 4Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 5Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 6Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 7Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 8Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 9Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 10Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 11Health News:SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results 12Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 2Health News:Align Technology Announces International Availability of Invisalign Teen(TM) 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 2Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 3Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 4Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 5Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 6Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 7Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 8Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 9Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 10Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 11Health News:IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results 12Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 2Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 3Health News:Alcohol-Branded Apparel Linked to Adolescent Drinking 4
Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing periosteal elevators, rounded edge, sharp, wide, blade width 5/8" (16 mm), length 7 1/4" (184 mm)....
Lederer periosteal elevators....
Medicine Products: